Ratings by BMO Capital (Connor Murphy)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/20/2026 Trevi Therapeutics TRVI New Coverage Outperform
(N/A)
19.07
(15.91)
-16.57% Details